Clinical trials recruiting in Siegen, Germany
11
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 3Not applicable 8
Conditions recruiting in Siegen, Germany
Recruiting trials in Siegen, Germany
- A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
- BAROSTIM THERAPY™ In Resistant Hypertension
- BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
- Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
- SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
- Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
Common questions
How many clinical trials are recruiting in Siegen, Germany?
11 recruiting trials have at least one study site in Siegen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.